Lawrenceville Urology
Lawrenceville, New Jersey 08648
0 studies enrolling now · 17 studies all time
What they study most
Androgen-insensitive Prostate Cancer, Benign Prostatic Hyperplasia, Bladder Cancer, Bladder Neoplasms, Bladder Tumors, Nocturia, Prostate Cancer, Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Bladder Cancer, Urinary Incontinence
Studies at this site
- Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer — Completed
- Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ — Completed
- A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer — Completed
- PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
- A Study of Degarelix in Patients With Prostate Cancer — Completed
- Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
- A Trial of Degarelix in Patients With Prostate Cancer — Completed
- R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence — Status unconfirmed
- A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy — Completed
- The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer — Completed
- A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer — Completed
- Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients — Stopped early
- Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia — Stopped early
- Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer — Completed
- Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder — Completed
- Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer — Completed
- Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) — Stopped early